Skip to main content
18
Number №3, 2025
First analysis of laboratory adherence in the Russian Federation to the sixth edition of the WHO laboratory manual for the examination and processing of human semen
Number №2, 2025
Post-Void Residual Urine Ratio (PVR-R) as a prognostic marker of chronic kidney disease in men with benign prostate hyperplasia
Number №1, 2025
The effect of testosterone replacement therapy on lower urinary tract symptoms (LUTS) in men
Number №4, 2024
The structure of damage of the genitourinary system in modern armed conflict
Number №3, 2024
Cost-effectiveness of urinary incontinence treatment in a short-stay hospital
Number №2, 2024
Complex medicines for correction of urine pH level during urolithiasis metaphylaxis
Number №1, 2024
Moscow program on histofusion biopsy of the prostate: results of a survey of practicing urologists based on data from a multicenter study
Number №4, 2023
Possibilities for improving the therapeutic activity of bacteriophage preparations Urological complications after renal transplantation
Number №3, 2023
Regulatory and legal possibilities for metaphylaxis of urolithiasis in the Russian Federation
Number №2, 2023
Frequency and nature of symptoms of dysfunction of the lower urinary tract in persons over 40 years old Postcoital cystitis as a cause of sexual dysfunction in women
Number №4, 2022
Surgical treatment of inferior vena cava tumor thrombus X-ray-free ureterolithotripsy for ureteral stones
Number №3, 2022
Brachytherapy for prostate cancer and immune response Risk factors for nephrolithiasis after radical cystectomy with intestinal plasty of the bladder
Number №2, 2022
The incidence of urolithiasis in the Russian Federation from 2005 to 2020 Urolithiasis and the risk of myocardial infarction and stroke
Number №1, 2022
A modern view on the screening of urolithiasis Hereditary factor of metaphylaxis of urolithiasis Treatment of infertility associated with a high level of sperm DNA fragmentation
Number №4, 2021
COVID-19 associated encrusting cystitis Endoscopic correction of vesicoureteral reflux in children: differentiated choice of method, material and dosage
Number №3, 2021
Artificial intelligence in urology oncology Mini-percutaneous nephrolithotomy without ureteral catheterization. Comparison with the standard method
Number №1, 2021
Epidemiological study of the prevalence of cystitis in women in the Voronezh region Congenital anomalies of the penis: world and domestic data
Number №5, 2020
Isolated kidney injury: international guidelines and Moscow standards
Number №3, 2020
Epidemiology of neurogenic urinary disorders. Treatment outcomes for high-risk prostate cancer patients: a multicenter analysis
Number №2, 2020
COVID-19: Impact on the Urological Service of the Russian Federation Genitourinary system and Covid-19: some aspects
Number №1, 2020
Distance education in urology. Experience 2012-2019 Inpatient care for urological patients in the context of the COVID-19 pandemic
Number №4, 2019
Male infertility in the Russian Federation: statistics for 2000-2018 Evaluation of the effectiveness of perineum muscle training in restoring erectile function
Number №3, 2019
Epidemiology of urolithiasis in the Perm region: results of a 30-year study The economic and economic rationale for the use of modern methods of treating urolithiasis
Номер №4, 2018
Incidence of ICD in the Russian Federation (2005-2016) Screening for prostate cancer: modern presentation and organization Primary multiple transitional cell epithelium Androgenic screening in men over 50 years
Номер №3, 2018
The role of stem cells in the treatment of urinary incontinence Percutaneous nephrolithotripsy in infected urine Testicular Prosthesis in Children and Adolescents: Results from a Multicenter Study Premature ejaculation is the current state of the problem.
Number №2, 2018
Alternative methods of treatment of localized prostate cancer Partial doubling of the urethra: paraurethral motion Comparative review of disposable flexible ureteronephroscope
Number №1, 2018
The prevalence of symptoms of impairment of the function of the lower urinary tract in men according to the results of a population study Patient-centered system of organization of medical care in urology using...
Number №4, 2017
Predicting the development of erectile dysfunction and cardiovascular diseases Prognostic factors of survival of patients with prostate cancer
Number №3, 2017
Recommendations for the treatment of prostate cancer with the help of high-power interstitial radiation therapy (brachytherapy)
Number №2, 2017

Radioisotope lymphoscintigraphy with PCa
Metabolic risk factors and formation of urinary stones
Ureteral amputation in the performance of contact ureterolithotrypsy

Number №1, 2017
Principles of «4P Medicine» in the organization of health care in the context of urological diseases Changes in the electrolyte composition of urine under the influence of sodium hypochlorite. The possibility of reducing the risk of recurrence of nephrolithiasis
Number №4, 2016
Preliminary results of a multicenter study of prostate cancer Analysis of specialized medical care for patients with gross hematuria, renal colic.
Number №3, 2016
Techniques for preserving continence after robot-prostatectomy The protective partial nephrectomy for renal cell carcinoma
Number №2, 2016
Медицинская помощь пациентам с острой задержкой мочеиспускания Прогностическое значение истинного кастрационного уровня тестостерона..
Number №1, 2016
The analysis of the accuracy of factors for the survival predictiry after radical cystectomy Citokine status in pathients with recurrent urinary tract infection
Number №4, 2015

Modern demographic situation in Russia Determination of gene mutations FGFR3 and PIK3CA DNA urine sediment from patients with bladder cancerя

Number №3, 2015
Neuroendocrine differentiation in cancer prostate. The role of viruses in carcinogenesis of bladder cancer.
Number №2, 2015
Clinical and economic evaluation of prostate cancer screening The combination RSAZ TMPRSS2-ERG in the diagnosis of prostate cancer: first experience
Number №1, 2015
The role of distance education in improving primary health care professionals. Comparative analysis of the results of cancer radical retropubic and robot-assisted prostatectomy.
Number №4, 2014
Experience of clinical and economical treatment cancer patients Comparison of analysis details for open, laparoscopic and robot-assisted nephrectomy in the..
Number №3, 2014
Medical and economic aspects of a comprehensive standardized program-stage diagnosis and treatment of benign prostatic hyperplasia
Number №2, 2014
Uronephrological morbidity and mortality in Russia in 2002-2012 Androgens and chronic ischemia PCA3 test-system: first results
Number №1, 2014
First results of standardized programme for BPH diagnosis and treatment Evaluation of serum Chromogranin A levels in different prostatic diseases Retarded ejaculation is a rare diagnosis
Number №4, 2013
Distance education in urology brachytherapy prostate cancer Erectile dysfunction and cardiovascular ...
Number №3, 2013
The incidence of kidney stones... HIFU-treatment of local recurrence of cancer... Non-prostatic sources of prostate...
Number №2, 2013
Risk factors for the development
of the urolithiasis in patients
with the metabolic syndrome
Number №1, 2013
Clinical and economic analysis of the surgical treatment of prostate cancer Brachytherapy prostate cancer: postimplantnaya dosimetry and dependence ... Simulation prostatic carcinogenesis
Number №4, 2012
Урологическая заболеваемость в Нижегородской области Стресс, метаболический синдром и хроническая болезнь почек TVT - 10 лет в России
Eksperimental'naya i klinicheskaya urologiya

Lithokinetic therapy after SWL: the possibilities of natural terpenes in combination with vitamin E

Number №1, 2021 - page 87-93
DOI: 10.29188/2222-8543-2021-14-1-87-93
For citation: Prosyannikov M.Yu., Zolotukhin O.V., Madykin Yu.Yu., Konstantinova O.V., Voytko D.A., Anokhin N.V., Sivkov A.V. Lithokinetic therapy after SWL: the possibilities of natural terpenes in combination with vitamin E. Experimental and Clinical Urology 2021;14(1):87-93, https://doi.org/10.29188/2222-8543-2021-14-1-87-93
M.Yu. Prosyannikov O.V. Zolotuhin Yu.Yu. Madykin O.V. Konstantinova D.A Voytko N.V. Anohin A.V. Sivkov
Information about authors:
  • Prosyannikov M.Yu. – PhD, head of the Department. Department of urolithiasis of N. Lopatkin Research Institute of urology and Interventional Radiology – branch of the National Medical Research Centre of Radiology of Ministry of health of Russian Federation; Moscow, Russia; https://orcid.org/0000-0003-3635-5244;
  • Zolotukhin O.V. – PhD, Deputy chief doctor of the Voronezh regional hospital №1, chief urologist of the Voronezh region; Voronezh, Russia; https://orcid.org/0000-0002-6742-3142
  • Konstantinova O.V. – Dr. Sc., Chief Researcher at the Department of urolithiasis of N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology – Branch of the National Medical Research Centre of Radiologyof the Ministry of Health of Russian Federation; Moscow, Russia; https://orcid.org/0000-0002-2214-7543
  • Madykin Yu.Yu. – associate Professor of Oncology, and specialized surgical discipline iаpe the VGMU of. N. N. Burdenko; Moscow, Russia; https://orcid.org/0000-0003-1178-2610
  • Voytko D.A. – PhD, Researcher of the Department of urolithiasis of N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology – Branch of the National Medical Research Centre of Radiology of the Ministry of Health of Russian Federation; Moscow, Russia; https://orcid.org/0000-0003-1292-1651
  • Anokhin N.V. – PhD, Researcher of the Department of urolithiasis of N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology – Branch of the National Medical Research Centre of Radiology of the Ministry of Health of Russian Federation; Moscow, Russia; https://orcid.org/0000-0002-4341-4276
  • Sivkov A.V. – PhD, deputy director on scientific work of N. Lopatkin Research Institute of urology and Interventional Radiology – branch of the National Medical Research Centre of Radiology of Ministry of health of Russian Federation; Moscow, Russia; https://orcid.org/0000-0001-8852-6485
6212
Download PDF

Introduction. Lithokinetic therapy after remote shock wave uretero lithotripsy (SWL) is an obligatory stage in the postoperative management of patients with urolithiasis. In the postoperative period, it is extremely important to correctly determine the required drug, its dosage and frequency of administration. According to clinical guidelines, it is customary to use standard schemes of lithokinetic therapy, including non-steroidal anti-inflammatory drugs (NSAIDs) in combination with α-blockers. However, the effectiveness of this therapy does not always lead to success. In this regard, the use of herbal remedies is additionally recommended. One of the phytopreparations is the biologically active additive Renotinex, which is a combination of essential oil (anethole), 6 natural terpenes and an oil solution of vitamin E.

Materials and methods. The study involved 100 patients with 4-10 mm ureteral stones after an SWL session. Patients were randomized into 2 groups: study and control, which included 50 patients each. The treatment was carried out for 28 days. Unlike patients in the control group, the patients of the main group, along with standard lithokinetic therapy (diclofenac, 1 suppository (50 mg) for pain, tamsulosin, 1 capsule (0.4 mg) in the morning), additionally received renotinex, 2 capsules 3 times a day. The effectiveness of the treatment was assessed 2 and 4 weeks after the start of therapy according to the data of ultrasound and X-ray research methods: by the presence of calculus its average size and the expansion of the pelvicellular system. As part of laboratory diagnostics, a general blood test was performed with an assessment of 3 parameters, such as: hemoglobin level, erythrocytes, leukocytes; general urine analysis with an assessment of 2 parameters (erythrocyturia and leukocyturia). For statistical analysis, Student's t test and Fisher's angular transformation method were used.

Results. The efficacy of combination therapy with renotinex after SWL of ureteral stones was 24% higher than that of standard lithokinetic therapy with NSAIDs and alpha-blockers; the significance of differences was obtained only after 4 weeks of therapy.

Сonclusions. The effectiveness of lithokinetic combination therapy in combination with renotinex after SWL of ureteral stones is higher than standard therapy, including NSAIDs and alpha-blockers.

Attachment Size
Download 1.88 MB
Keywords: urolithiasis disease; phytotherapy; lithokinetic therapy.